These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 26122820)

  • 1. KRAS and aneusomy of chromosomes 4, 10 and 12 in colorectal carcinomas.
    Beyer K; Altendorf-Hofmann A; Chen Y; Bickel K; Petersen I
    Pathol Res Pract; 2015 Sep; 211(9):646-51. PubMed ID: 26122820
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Colorectal poorly differentiated neuroendocrine carcinomas frequently exhibit BRAF mutations and are associated with poor overall survival.
    Olevian DC; Nikiforova MN; Chiosea S; Sun W; Bahary N; Kuan SF; Pai RK
    Hum Pathol; 2016 Mar; 49():124-34. PubMed ID: 26826419
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Low incidence of KRAS, BRAF, and PIK3CA mutations in adenocarcinomas of the ampulla of Vater and their prognostic value.
    Kwon MJ; Kim JW; Jung JP; Cho JW; Nam ES; Cho SJ; Kim JS; Park HR; Min SK; Seo J; Min KW; Kim DH; Jeon JY
    Hum Pathol; 2016 Apr; 50():90-100. PubMed ID: 26997442
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mutant allele-specific imbalance modulates prognostic impact of KRAS mutations in colorectal adenocarcinoma and is associated with worse overall survival.
    Hartman DJ; Davison JM; Foxwell TJ; Nikiforova MN; Chiosea SI
    Int J Cancer; 2012 Oct; 131(8):1810-7. PubMed ID: 22290300
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High frequency of KRAS mutation in early onset colorectal adenocarcinoma: implications for pathogenesis.
    Watson R; Liu TC; Ruzinova MB
    Hum Pathol; 2016 Oct; 56():163-70. PubMed ID: 27346571
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic significance of alterations in KRAS isoforms KRAS-4A/4B and KRAS mutations in colorectal carcinoma.
    Abubaker J; Bavi P; Al-Haqawi W; Sultana M; Al-Harbi S; Al-Sanea N; Abduljabbar A; Ashari LH; Alhomoud S; Al-Dayel F; Uddin S; Al-Kuraya KS
    J Pathol; 2009 Dec; 219(4):435-45. PubMed ID: 19824059
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical and pathological significance of numerical aberrations of chromosomes 11 and 17 in colorectal neoplasms.
    Tagawa Y; Yasutake T; Sawai T; Nanashima A; Jibiki M; Morinaga M; Akama F; Nakagoe T; Ayabe H
    Clin Cancer Res; 1997 Sep; 3(9):1587-92. PubMed ID: 9815847
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinicopathologic and prognostic associations of KRAS and BRAF mutations in small intestinal adenocarcinoma.
    Jun SY; Kim M; Jin Gu M; Kyung Bae Y; Chang HK; Sun Jung E; Jang KT; Kim J; Yu E; Woon Eom D; Hong SM
    Mod Pathol; 2016 Apr; 29(4):402-15. PubMed ID: 26892442
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of KRAS mutation on outcome of patients with metastatic colorectal cancer.
    Chang YY; Lin JK; Lin TC; Chen WS; Jeng KJ; Yang SH; Wang HS; Lan YT; Lin CC; Liang WY; Chang SC
    Hepatogastroenterology; 2014 Oct; 61(135):1946-53. PubMed ID: 25713893
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Utility of comprehensive genomic sequencing for detecting HER2-positive colorectal cancer.
    Shimada Y; Yagi R; Kameyama H; Nagahashi M; Ichikawa H; Tajima Y; Okamura T; Nakano M; Nakano M; Sato Y; Matsuzawa T; Sakata J; Kobayashi T; Nogami H; Maruyama S; Takii Y; Kawasaki T; Homma KI; Izutsu H; Kodama K; Ring JE; Protopopov A; Lyle S; Okuda S; Akazawa K; Wakai T
    Hum Pathol; 2017 Aug; 66():1-9. PubMed ID: 28235632
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High mesothelin expression in advanced lung adenocarcinoma is associated with KRAS mutations and a poor prognosis.
    Thomas A; Chen Y; Steinberg SM; Luo J; Pack S; Raffeld M; Abdullaev Z; Alewine C; Rajan A; Giaccone G; Pastan I; Miettinen M; Hassan R
    Oncotarget; 2015 May; 6(13):11694-703. PubMed ID: 26028668
    [TBL] [Abstract][Full Text] [Related]  

  • 12. KRAS mutant allele-specific imbalance in lung adenocarcinoma.
    Chiosea SI; Sherer CK; Jelic T; Dacic S
    Mod Pathol; 2011 Dec; 24(12):1571-7. PubMed ID: 21743433
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Numerical aberrations of chromosomes 1 and 7 by fluorescent in situ hybridization and DNA ploidy analysis in breast cancer.
    Kapranos N; Kounelis S; Karantasis H; Kouri E
    Breast J; 2005; 11(6):448-53. PubMed ID: 16297090
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Copy number alterations of chromosomal regions enclosing protein tyrosine phosphatase receptor-like genes in colorectal cancer.
    Laczmanska I; Karpinski P; Kozlowska J; Bebenek M; Ramsey D; Sedziak T; Ziolkowski P; Sasiadek MM
    Pathol Res Pract; 2014 Dec; 210(12):893-6. PubMed ID: 25169130
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alteration of numerical chromosomal aberrations during progression of colorectal tumors revealed by a combined fluorescence in situ hybridization and DNA ploidy analysis of intratumoral heterogeneity.
    Katsura K; Sugihara H; Nakai S; Fujita S
    Cancer Genet Cytogenet; 1996 Sep; 90(2):146-53. PubMed ID: 8830725
    [TBL] [Abstract][Full Text] [Related]  

  • 16. KRAS Status as an Independent Prognostic Factor for Survival after Yttrium-90 Radioembolization Therapy for Unresectable Colorectal Cancer Liver Metastases.
    Lahti SJ; Xing M; Zhang D; Lee JJ; Magnetta MJ; Kim HS
    J Vasc Interv Radiol; 2015 Aug; 26(8):1102-11. PubMed ID: 26210240
    [TBL] [Abstract][Full Text] [Related]  

  • 17. KRAS mutations in codon 12 or 13 are associated with worse prognosis in pancreatic ductal adenocarcinoma.
    Sinn BV; Striefler JK; Rudl MA; Lehmann A; Bahra M; Denkert C; Sinn M; Stieler J; Klauschen F; Budczies J; Weichert W; Stenzinger A; Kamphues C; Dietel M; Riess H
    Pancreas; 2014 May; 43(4):578-83. PubMed ID: 24681874
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detection of
    Olmedillas-López S; Lévano-Linares DC; Alexandre CLA; Vega-Clemente L; Sánchez EL; Villagrasa A; Ruíz-Tovar J; García-Arranz M; García-Olmo D
    World J Gastroenterol; 2017 Oct; 23(39):7087-7097. PubMed ID: 29093617
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Significance of Combined Measurement of p53 Antibody and other Tumor Markers for Colorectal Cancer after Curative Resection.
    Kawahara D; Fujita F; Hayashi H; Matsuyama T; Eguchi S
    Hepatogastroenterology; 2015 May; 62(139):624-8. PubMed ID: 26897942
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Near-diploid and near-triploid human sporadic colorectal adenocarcinomas differ for KRAS2 and TP53 mutational status.
    Giaretti W; Venesio T; Sciutto A; Prevosto C; Geido E; Risio M
    Genes Chromosomes Cancer; 2003 Jun; 37(2):207-13. PubMed ID: 12696070
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.